Experts Debate Aspirin for Primary Prevention in Type 2 Diabetes Experts Debate Aspirin for Primary Prevention in Type 2 Diabetes
At IDF 2021, two speakers presented different views on the benefit-risk balance of cardiovascular protection versus bleeding risk in those who haven ' t already had a vascular event.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
More News: Aspirin | Bleeding | Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart